Moreover, in an even more recent report, it has been confirmed that CK2 inhibitor (CX-4945) strongly suppresses the expression of WD Repeat-Containing Protein 5 (WDR5) in T-ALL by restoring Ikaros gene function. The gene discussed is WDR5; the disease is acute lymphoblastic leukemia.